Medicines

The International Pharmacopoeia (Ph. Int.): Anti-infective medicines
Antibacterial, antiprotozoal, antifungal, antiviral, and antimycobacterial agents (for diseases other than HIV/AIDS, TB and malaria), anthelmintics

Published monographs

Monographs for a range of anti-infective substances and dosage forms are published in the fourth Edition of The International Pharmacopoeia.

International Chemical Reference Substances (ICRS)

The International Chemical Reference Substances (ICRS) required to support the monograph specifications in The International Pharmacopoeia are established on the advice of the WHO Expert Committee on Specifications for Pharmaceutical Preparations by the WHO Collaborating Centre for Chemical Reference Substances. Information about the ICRS is available from the centre.

Proposals for inclusion

It is proposed to include monographs for the following substances and dosage forms. Letters are being sent to known manufacturers of these items inviting them to co-operate in the development of these monographs for publication. Any manufacturers not directly contacted are hereby invited to submit proposals for appropriate specifications and analytical procedures. For further information, please contact: E-mail: qsm@who.int

Antibacterial agents

APIs

  • Ceftriaxone sodium

Dosage forms

  • Ceftriaxone injection
  • Doxycycline dispersible tablets
  • Sulfamethoxazole/trimethoprim injection
  • Sulfamethoxazole/trimethoprim oral liquid

Antiprotozoal, antifungal and antimycobacterial agents

APIs

  • Fluconazole

Dosage forms

  • Fluconazole capsules
  • Fluconazole injection
  • Fluconazole oral liquid

Anthelmintics

APIs

  • Ivermectin

Dosage forms

  • Albendazole chewable tablets
  • Ivermectin tablets
  • Pyrantel oral liquid
Monographs in preparation

Collaborative work is currently being carried out on the development of monographs for the following substances and dosage forms. Draft specifications will circulate for public comment.

Adopted monographs

The monographs listed here have been adopted by the Expert Committee on Specifications for Pharmaceutical Preparations for addition to the forthcoming issue of the International Pharmacopoeia.

Share